The THS/PH210 is a high-performance Pharmaceutical Metal Detector made of AISI 316L stainless steel with a mirror-polished finish, specifically engineered for high-throughput production lines. This model delivers 50% superior detection sensitivity compared to the THS/PH21N, ensuring maximum protection against metallic contaminants. Fully compliant with FDA 21 CFR Parts 210, 211, and Part 11 regulations, it features advanced Multi-Point Auto-learn technology, enhanced traceability, and an internal memory capable of logging up to 500,000 events. The system includes real-time monitoring sensors for the ejection process and comprehensive industrial connectivity. Designed for hygienic excellence, all product-contact components can be disassembled rapidly without tools, ensuring easy maintenance and peak operational efficiency.
- Home
- Tablets and Capsules
Tablets and Capsules
The THS/PH21 series inspection systems are specifically designed for the Pharmaceutical and Nutraceutical industry, guaranteeing maximum safety in the analysis of tablets and capsules. Thanks to their compact structure and the ability to handle high product flows, these Metal Detectors integrate perfectly downstream of tablet presses, capsulating machines, or dedusters, intercepting every minimal metal contamination (ferromagnetic, non-ferromagnetic, and stainless steel).
The main application is by gravity fall: products pass through the Metal Detector aperture and, thanks to advanced technologies such as Multi-Point auto-learn, it is possible to accurately distinguish the product signal from that of metals. In the event of contamination, the system instantly activates the rejection devices to discard the contaminated product, ensuring that only compliant product reaches the final packaging.
These instruments allow for additional results:
- Quality Assurance: Functions such as AUTOTEST and AUTO-QC constantly verify the machine's performance without interrupting production.
- Traceability and Compliance: Event logging ensures full compliance with FDA CFR21 Part 11 regulations.
- Advanced Analysis: Research and development activities or the analysis of rejected samples, facilitating the identification of the metal contamination source.
